Yuan H - Search Results

1

Optimization of the Prodrug Moiety of Remdesivir to Improve Lung Exposure/Selectivity and Enhance Anti-SARS-CoV-2 Activity.

Hu H, Mady Traore MD, Li R, Yuan H, He M, Wen B, Gao W, Jonsson CB, Fitzpatrick EA, Sun D. Hu H, et al. Among authors: yuan h. J Med Chem. 2022 Sep 22;65(18):12044-12054. doi: 10.1021/acs.jmedchem.2c00758. Epub 2022 Sep 7. J Med Chem. 2022. PMID: 36070561

2

CPA4 is a Novel Diagnostic and Prognostic Marker for Human Non-Small-Cell Lung Cancer.

Sun L, Wang Y, Yuan H, Burnett J, Pan J, Yang Z, Ran Y, Myers I, Sun D. Sun L, et al. Among authors: yuan h. J Cancer. 2016 Jun 18;7(10):1197-204. doi: 10.7150/jca.15209. eCollection 2016. J Cancer. 2016. PMID: 27390594 Free PMC article.

3

Overexpression of carboxypeptidase A4 (CPA4) is associated with poor prognosis in patients with gastric cancer.

Sun L, Guo C, Yuan H, Burnett J, Pan J, Yang Z, Ran Y, Myers I, Sun D. Sun L, et al. Among authors: yuan h. Am J Transl Res. 2016 Nov 15;8(11):5071-5075. eCollection 2016. Am J Transl Res. 2016. PMID: 27904708 Free PMC article.

4

Distinct biodistribution of doxorubicin and the altered dispositions mediated by different liposomal formulations.

Luo R, Li Y, He M, Zhang H, Yuan H, Johnson M, Palmisano M, Zhou S, Sun D. Luo R, et al. Among authors: yuan h. Int J Pharm. 2017 Mar 15;519(1-2):1-10. doi: 10.1016/j.ijpharm.2017.01.002. Epub 2017 Jan 4. Int J Pharm. 2017. PMID: 28063903

5

Litchi seed extracts diminish prostate cancer progression via induction of apoptosis and attenuation of EMT through Akt/GSK-3β signaling.

Guo H, Luo H, Yuan H, Xia Y, Shu P, Huang X, Lu Y, Liu X, Keller ET, Sun D, Deng J, Zhang J. Guo H, et al. Among authors: yuan h. Sci Rep. 2017 Jan 30;7:41656. doi: 10.1038/srep41656. Sci Rep. 2017. PMID: 28134352 Free PMC article.

6

Engineering exosomes as refined biological nanoplatforms for drug delivery.

Luan X, Sansanaphongpricha K, Myers I, Chen H, Yuan H, Sun D. Luan X, et al. Among authors: yuan h. Acta Pharmacol Sin. 2017 Jun;38(6):754-763. doi: 10.1038/aps.2017.12. Epub 2017 Apr 10. Acta Pharmacol Sin. 2017. PMID: 28392567 Free PMC article. Review.

7

Different Nanoformulations Alter the Tissue Distribution of Paclitaxel, Which Aligns with Reported Distinct Efficacy and Safety Profiles.

Li F, Zhang H, He M, Liao J, Chen N, Li Y, Zhou S, Palmisano M, Yu A, Pai MP, Yuan H, Sun D. Li F, et al. Among authors: yuan h. Mol Pharm. 2018 Oct 1;15(10):4505-4516. doi: 10.1021/acs.molpharmaceut.8b00527. Epub 2018 Sep 21. Mol Pharm. 2018. PMID: 30180593 Free PMC article.

8

Species difference in paclitaxel disposition correlated with poor pharmacological efficacy translation from mice to humans.

Li YF, Zhang C, Zhou S, He M, Zhang H, Chen N, Li F, Luan X, Pai M, Yuan H, Sun D, Li Y. Li YF, et al. Among authors: yuan h. Clin Pharmacol. 2018 Nov 8;10:165-174. doi: 10.2147/CPAA.S185449. eCollection 2018. Clin Pharmacol. 2018. PMID: 30519122 Free PMC article.

9

MEOX1 Promotes Tumor Progression and Predicts Poor Prognosis in Human Non-Small-Cell Lung Cancer.

Sun L, Yuan H, Burnett J, Gasparyan M, Zhang Y, Zhang F, Yang Z, Ran Y, Sun D. Sun L, et al. Among authors: yuan h. Int J Med Sci. 2019 Jan 1;16(1):68-74. doi: 10.7150/ijms.27595. eCollection 2019. Int J Med Sci. 2019. PMID: 30662330 Free PMC article.

10

Neonatal Fc Receptor (FcRn) Enhances Tissue Distribution and Prevents Excretion of nab-Paclitaxel.

Li F, Yuan H, Zhang H, He M, Liao J, Chen N, Li Y, Zhou S, Palmisano M, Yu A, Pai M, Sun D. Li F, et al. Among authors: yuan h. Mol Pharm. 2019 Jun 3;16(6):2385-2393. doi: 10.1021/acs.molpharmaceut.8b01314. Epub 2019 May 1. Mol Pharm. 2019. PMID: 31002261 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,037 results

Search Page

Filters